PII Acquires Pharmaterials Ltd

BALTIMORE, Md., January 3, 2008 – PII (Pharmaceutics International, Inc.) has acquired Pharmaterials Ltd (Reading, UK), an internationally renowned preformulation and formulation development company. This acquisition will extend the business development initiatives and increase the value of the service offerings of PII.


Steve King, Senior VP of PII stated “PII offers a very wide range of cGMP production and formulation development services which have been expanded through alliances in drug delivery ventures. This acquisition of Pharmaterials will enable PII to provide a complete service for our customer base. ”


Professor Graham Buckton, Chief Executive and founder of Pharmaterials, said “PII is a company that provides an excellent service to their wide client base. They have a state of the art facility with a staff of over 300 providing formulation and manufacturing services. The success that they have seen is based on providing value to their customers, which is the same philosophy at Pharmaterials. Working together we will be able to provide preformulation, polymorphism, salt screening and co-crystal services to PII’s existing customers. In addition, they can provide new options in cGMP transfer to enhance services at Pharmaterials.”


PII (www.pharm-int.com) is a contract formulation development, Clinical Trail Materials (CTM) and commercial manufacturing company based in Hunt Valley, Maryland. Founded in 1994, PII can manufacture most solid and semi-solid dosage forms for use in clinical trials and commercial sale. These services are complemented by full analytical and regulatory support. The state of the art cGMP facility contains on-site manufacturing suites, analytical laboratories and warehouse space. The company has a balanced client base of major multinational and virtual pharmaceutical companies that are primarily focused in the United States and Europe.

Pharmaterials Ltd (www.pharmaterials.co.uk) is a technology driven contract research organization specializing in the optimization of drug substance physical forms and formulations to facilitate the development of low solubility and poorly permeable drug substances. With partnerships that span the globe, Pharmaterials works with a range of organizations including start-up, mid-size and multinational companies. Founded in January 2000 by Professor Graham Buckton, the company has exponentially expanded through implementation of an organic business model. Pharmaterials is housed in state-of-the-art laboratories and offices in Reading, UK and has offices in Tokyo to support their increasing Japanese client base.

####

Contact:
Steve King, Sr. Vice President
Pharmaceutics International, Inc.
10819 Gilroy Road
Hunt Valley, MD 21031
Phone: 410 584-0001
Email: sjking@pharm-int.com

Posted: January 2008


View comments

Hide
(web5)